Angiotensin converting enzyme inhibitors could provide neuroprotection via blockade of angiotensin II-mediated endothelial dysfunction, lipid peroxidation and subsequent oxidative stress, and vascular smooth muscle intracellular calcium accumulation and hypertrophy [14-20]. The gene discussed is AGT; the disease is endothelial dysfunction.